🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
1.810
-0.050 (-2.69%)
At close: Nov 20, 2026, 4:00 PM EST
1.840
+0.030 (1.66%)
After-hours: Nov 20, 2026, 5:33 PM EST

BBOT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
1451,001247-
Market Cap Growth
-85.68%305.70%--
Enterprise Value
-168536--
Last Close Price
1.8112.5210.50-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
PB Ratio
0.492.441.71-
P/TBV Ratio
0.502.44--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.010.01--
Net Debt / Equity Ratio
-1.07-1.03-1.070.02
Net Debt / EBITDA Ratio
1.672.901.930.00
Net Debt / FCF Ratio
2.073.692.830.01
Quick Ratio
3.8012.157.950.12
Current Ratio
4.0812.348.110.24
Return on Equity (ROE)
-46.36%-48.23%-110.95%-
Return on Assets (ROA)
-41.28%-43.76%-87.26%-1088.84%
Return on Capital Employed (ROCE)
-63.40%-35.30%-55.90%597.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-118.15%-13.38%-30.09%-
FCF Yield
-103.98%-11.43%-22.31%-
Buyback Yield / Dilution
-628.00%-241276.23%89.66%-